{"id":251325,"date":"2021-12-01T00:00:00","date_gmt":"2021-12-01T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidid0025-biopharma-hepatitis-b-virus-epidemiology-americas\/"},"modified":"2026-03-31T10:41:50","modified_gmt":"2026-03-31T10:41:50","slug":"epidid0025-biopharma-hepatitis-b-virus-epidemiology-americas","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidid0025-biopharma-hepatitis-b-virus-epidemiology-americas\/","title":{"rendered":"Hepatitis B Virus &#8211; Epidemiology &#8211; Americas"},"content":{"rendered":"<p>Clarivate Epidemiology\u2019s coverage of hepatitis B virus (<abbr title=\"hepatitis B virus\">HBV<\/abbr>) infection comprises epidemiological estimates of key patient populations in 45 countries. We report the total prevalence of <abbr title=\"hepatitis B virus\">HBV<\/abbr> infection for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>The patient populations are forecast over a period of 10 years for all countries.<\/p>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>Clarivate Epidemiology\u2019s <abbr title=\"hepatitis B virus\">HBV<\/abbr> infection forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>How will changes in <abbr title=\"hepatitis B virus\">HBV<\/abbr> vaccine coverage impact the prevalence of <abbr title=\"hepatitis B virus\">HBV<\/abbr> infections?<\/li>\n<li>Of all people diagnosed with <abbr title=\"hepatitis B virus\">HBV<\/abbr> infection, what percentage in each of the major pharmaceutical markets are drug-treated?<\/li>\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <abbr title=\"hepatitis B virus\">HBV<\/abbr> infection over the forecast period?<\/li>\n<\/ul>\n","protected":false},"template":"","class_list":["post-251325","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-hepatitis-b-virus","biopharma-product-epidemiology","biopharma-geography-us","biopharma-date-950"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251325\/revisions"}],"predecessor-version":[{"id":283762,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251325\/revisions\/283762"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=251325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}